Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts
P. Joly(Inserm), Luis A. Díaz(Memorial Sloan Kettering Cancer Center), Animesh A. Sinha(University at Buffalo, State University of New York), David T. Woodley(University of Southern California), Giovanna Zambruno(Bambino Gesù Children's Hospital), Daniel Mimouni(Rabin Medical Center), Hiroshi Shimizu(The University of Tokyo), Janet A. Fairley(Medical College of Wisconsin), Philippe Bernard(Hôpital Dupuytren), Valéria Aoki(Universidade de São Paulo), Russell P. Hall(Duke University), José M. Mascaró(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), David Sirois(Rutgers, The State University of New Jersey), Carlo Pincelli(University of Modena and Reggio Emilia), David A. Rubenstein(University of North Carolina at Chapel Hill), Michael Hertl(Universitätsklinikum Gießen und Marburg), Takashi Hashimoto(Osaka Metropolitan University), Branka Marinović(University Hospital Centre Zagreb), Robert A. Swerlick(Emory University), Enno Schmidt(Carrier (United States)), Giuseppe Cianchini(Istituto Dermopatico dell'Immacolata), Masayuki Amagai(Keio University), Amit G. Pandya(The University of Texas Southwestern Medical Center), John J. Zone(University of Utah), Luca Borradori(University Dermatology), Marcel F. Jonkman(University Medical Center Groningen), Benjamin S. Daniel(Royal Children's Hospital), Detlef Zillikens(University of Lübeck), Dédée F. Murrell(Sutherland Hospital), Michael Meurer(University Hospital Carl Gustav Carus), Aimee Payne(Columbia University Irving Medical Center)
Cited by 0
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Cancer Genome Landscapes
|Science|2013|8k
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
|New England Journal of Medicine|2020|2.9k